paxilline has been researched along with dasatinib in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
Ashton, GH; Brunton, VG; Clark, EA; Evans, TR; Frame, MC; Lee, FY; Macpherson, IR; Sansom, OJ; Serrels, A | 1 |
Calcabrini, A; Gómez-Domínguez, D; Gómez-López, G; Martín-Forero, E; Martín-Pérez, J; Molinari, A; Morte, B; Sánchez-Bailón, MP; Wagner, KU | 1 |
Cushman, I; Hurwitz, HI; Jia, J; Liu, Y; Marshall, DJ; Nixon, AB; Starodub, A | 1 |
Chen, CY; Chen, YC; Cheng, YW; Lee, H; Lee, MC; Wu, DW; Wu, JY; Wu, TC | 1 |
Adams, DJ; Grace, L; Jia, J; Murphy, SK; Nixon, AB; Secord, AA; Teoh, D | 1 |
Huang, CC; Lee, H; Lin, PL; Wu, DW | 1 |
Aitchison, M; Edwards, J; Fraser, S; Hammond, R; Jones, RJ; Lim, Z; MacDonald, AI; Oades, GM; Qayyum, T; Roseweir, AK | 1 |
Feng, X; Hao, Y; Khalil, AM; Scott, A; Somasundaram, S; Wang, Z; Willis, J; Zhang, P; Zhao, Y | 1 |
Bekiranov, S; Gioeli, D; Hall, S; Jameson, MJ; Lehman, CE; Petricoin, EF; Shaw, JJP; Spencer, A; Wulfkuhle, J | 1 |
10 other study(ies) available for paxilline and dasatinib
Article | Year |
---|---|
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib.
Topics: Animals; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Dasatinib; Dose-Response Relationship, Drug; Epithelial Cells; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Leukocytes, Mononuclear; Mice; Mice, Nude; Paxillin; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles | 2006 |
Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Female; Humans; Indoles; Neoplasm Invasiveness; Paxillin; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Sulfonamides; Thiazoles | 2012 |
Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Dasatinib; Focal Adhesion Kinase 1; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaV; Paxillin; Phosphorylation; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles | 2013 |
Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Dasatinib; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Paxillin; Phosphorylation; Pyrimidines; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Dasatinib; Deoxycytidine; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gemcitabine; Humans; Paxillin; Pyrimidines; Signal Transduction; src-Family Kinases; Taxoids; Thiazoles; Topotecan | 2014 |
Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.
Topics: Animals; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Colorectal Neoplasms; Dasatinib; Enzyme Activation; Enzyme Induction; Extracellular Signal-Regulated MAP Kinases; Heterografts; Humans; Kaplan-Meier Estimate; Leupeptins; Lung Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Paxillin; Phosphorylation; Proportional Hazards Models; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Sulfonamides | 2015 |
Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dasatinib; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Paxillin; Prognosis; Signal Transduction; src-Family Kinases; Tissue Array Analysis | 2016 |
Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Colonic Neoplasms; Crk-Associated Substrate Protein; Dasatinib; Female; Genes, APC; Humans; Immunohistochemistry; Male; Mice; Microsatellite Instability; Models, Biological; Neoplasm Staging; Paxillin; Phosphatidylinositol 3-Kinases; Phosphorylation; Prognosis; Proto-Oncogene Proteins c-akt; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Signal Transduction; src-Family Kinases | 2017 |
IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dasatinib; Drug Synergism; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Indoles; Paxillin; Phosphorylation; Protein Array Analysis; Pyrazoles; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Sulfonamides; Triazines | 2021 |